Bausch Health Companies Inc
NYSE:BHC
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
5.22
10.61
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
Abbvie Inc
NYSE:ABBV
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Realty Income Corp
NYSE:O
|
US |
|
|
Walt Disney Co
NYSE:DIS
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Bausch Health Companies Inc
Revenue
Bausch Health Companies Inc
Revenue Peer Comparison
SNDL
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
B
|
Bausch Health Companies Inc
NYSE:BHC
|
Revenue
$9.2B
|
CAGR 3-Years
3%
|
CAGR 5-Years
2%
|
CAGR 10-Years
2%
|
|
|
Sundial Growers Inc
NASDAQ:SNDL
|
Revenue
CA$909m
|
CAGR 3-Years
146%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
C
|
Cronos Group Inc
NASDAQ:CRON
|
Revenue
$101.8m
|
CAGR 3-Years
22%
|
CAGR 5-Years
39%
|
CAGR 10-Years
N/A
|
|
C
|
Curaleaf Holdings Inc
CNSX:CURA
|
Revenue
$2.3B
|
CAGR 3-Years
71%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
T
|
Terrascend Corp
CNSX:TER
|
Revenue
$247.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Bausch Health Companies Inc
Revenue Breakdown
Breakdown by Geography
Bausch Health Companies Inc
|
Total Revenue:
8.8B
USD
|
|
United States And Puerto Rico:
5.2B
USD
|
|
Other:
1B
USD
|
|
China:
441m
USD
|
|
Canada:
366m
USD
|
|
Mexico:
322m
USD
|
|
Poland:
319m
USD
|
|
France:
214m
USD
|
|
Japan:
194m
USD
|
|
Germany:
152m
USD
|
|
Russia:
148m
USD
|
|
United Kingdom:
125m
USD
|
|
South Korea:
93m
USD
|
|
Spain:
92m
USD
|
|
Italy:
86m
USD
|
Breakdown by Segments
Bausch Health Companies Inc
|
Total Revenue:
8.8B
USD
|
|
Product Sales:
8.7B
USD
|
|
Bausch + Lomb:
4.1B
USD
|
|
Pharmaceuticals:
3.9B
USD
|
|
Salix:
2.3B
USD
|
|
Devices:
2B
USD
|
|
Otc:
1.8B
USD
|
|
International:
1.1B
USD
|
|
Branded And Other Generics:
960m
USD
|
|
Diversified:
943m
USD
|
|
Solta Medical:
347m
USD
|
|
Other Revenues:
94m
USD
|
|
Price Appreciation Credit:
11m
USD
|
See Also
What is Bausch Health Companies Inc's Revenue?
Revenue
9.2B
USD
Based on the financial report for Jun 30, 2024, Bausch Health Companies Inc's Revenue amounts to 9.2B USD.
What is Bausch Health Companies Inc's Revenue growth rate?
Revenue CAGR 10Y
2%
Over the last year, the Revenue growth was 10%. The average annual Revenue growth rates for Bausch Health Companies Inc have been 3% over the past three years , 2% over the past five years , and 2% over the past ten years .
You don't have any saved screeners yet
